American Oriental Bioengineering, Inc., (NYSE: AOB) based in Shenzhen, China, engages in the development, manufacture, and commercialization pharmaceutical and healthcare products.
It offers prescription, over-the-counter (OTC) and nutraceutical products for viral infections, women and children’s health. Its OTC products target bedwetting and incontinence; endometritis, annexitis, and pelvic inflammations; premenstrual syndrome (PMS), and other PMS and menopause-related symptoms; and sinus congestion from common cold, stuffy nose, chronic rhinitis, allergic rhinitis, and nasosinusitis.
The company’s nutraceutical products include soy peptide products series for overall health. It sells its products primarily to hospitals, clinics, pharmacies, and retail outlets in China.
WHY SHOULD YOU INVEST IN AOBO?
Strong financial performance
Sizeable market opportunity